NKGen Biotech, Inc. Common Stock
NKGN · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29,414 | $6,598 | -$16,088 | -$5,382 |
| Dep. & Amort. | $331 | $332 | $326 | $326 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $835 | $1,093 | $1,097 | $1,117 |
| Change in WC | -$4,045 | $1,647 | $123 | $2,275 |
| Other Non-Cash | $25,340 | -$13,565 | $8,543 | -$601 |
| Operating Cash Flow | -$6,953 | -$3,895 | -$5,999 | -$4,034 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $17 | -$17 | $0 | $0 |
| Net Acquisitions | -$35 | $0 | $0 | $35 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $2 | $0 | -$15 | $0 |
| Investing Cash Flow | -$16 | -$17 | -$15 | $35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10,496 | $2,528 | $6,494 | $1,474 |
| Stock Issued | -$249 | $99 | $0 | $250 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $17,562 | $1,193 | -$435 | $2,533 |
| Financing Cash Flow | $6,967 | $3,820 | $6,059 | $4,007 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,738 | -$92 | $45 | $8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $237 | $329 | $284 | $276 |
| End Cash | $1,975 | $237 | $329 | $284 |
| Free Cash Flow | -$6,936 | -$3,912 | -$5,999 | -$4,034 |